Copyright
©The Author(s) 2018.
World J Diabetes. Nov 15, 2018; 9(11): 199-205
Published online Nov 15, 2018. doi: 10.4239/wjd.v9.i11.199
Published online Nov 15, 2018. doi: 10.4239/wjd.v9.i11.199
| System | Clinical effects |
| Cardiovascular | Depressed myocardium contractility |
| Changes in SVR | |
| Acidosis-aided catecholamine release opposes acidosis-mediated vasodilation. | |
| Net SVR depends on the sum of both effects | |
| Conduction defects and dysrhythmias | |
| Impaired response to exogenous vasopressors | |
| Pulmonary | Increased work of breathing and respiratory failure |
| Compensatory alveolar hyperventilation | |
| Dyspnea (Kussmaul’s breathing) | |
| Acute decrease in hemoglobin oxygen affinity (Bohr Effect) | |
| Temporary: Affinity rises after 36 h due to depletion of RBC 2,3-DPG | |
| Renal | Pseudo-hyperkalemia |
| Hyperuricemia | |
| Hypercalcemia | |
| Hematological effect | Impaired coagulation |
| Thrombocytopenia | |
| Reduced fibrinogen and thrombin formation | |
| Impaired clotting factor function | |
| Factor Va | |
| Factor VIIa | |
| Factor VIIa/tissue factor complex | |
| Endocrine | Insulin resistance |
| Catecholamine, cortisol, PTH and aldosterone stimulation | |
| Bone demineralization | |
| Protein wasting | |
| Free radical formation | |
| Musculoskeletal system | Anti-anabolic effect on the bone growth centers in chronic metabolic acidosis |
| Muscle fatigue | |
| Central nerve system | Cerebral edema |
| Depressed sensorium | |
| Immune system | Impaired leukocyte function |
| Increased susceptibility to infections |
Table 2 Key findings and conclusions regarding the use of sodium bicarbonate in diabetic ketoacidosis
| Sodium bicarbonate use in mild to moderate acidemia (pH ≥ 7.0) is associated with |
| No benefit in mortality or duration of hospitalization[12] |
| Possible transient benefit in reversal of acidosis[12,14,16] |
| Delay in resolution of ketosis[18] |
| Trend toward worsening of central nervous system acidosis[15] |
| Increased need for potassium supplementation[16] |
| Worsened tissue hypoxia[19] |
| Cerebral edema and prolonged hospitalization in pediatric patients[12] |
| Post-treatment metabolic alkalosis |
| Sodium bicarbonate use in severe acidemia (pH < 7.0) has not been well-studied |
| No improvement in morbidity or mortality in a small, randomized trial[15] |
| Routine use of sodium bicarbonate in diabetic ketoacidosis is not supported by the available literature |
| Several situations exist in which the use of sodium bicarbonate may be warranted |
| Severe acidosis |
| Life-threatening hyperkalemia |
| Recovery from saline-induced metabolic acidosis |
Table 3 Key findings and conclusions regarding blood gas monitoring in diabetic ketoacidosis
| Venous blood is similar to arterial sampling in measuring |
| pH[21-25] |
| Bicarbonate[21,24] |
| Lactate[21] |
| Base excess[21] |
| Venous blood gas measurement may be used in place of arterial blood for the purposes of stratifying disease severity in diabetic ketoacidosis |
| Blood gas measurement does not often change management of diabetic ketoacidosis, especially when routine chemistries (including bicarbonate level) and ketone body identification are available[25] |
| Routine use of arterial and/or venous blood gas measurement may not be necessary in the evaluation and management of diabetic ketoacidosis |
| Exceptions where blood gas analysis would likely alter management include |
| Abnormal baseline serum bicarbonate levels |
| Chronic respiratory failure |
| Renal tubular acidosis |
| Acute respiratory compromise |
| Adequacy of respiratory compensation for metabolic acidosis |
| Respiratory muscle fatigue and failure |
- Citation: Patel MP, Ahmed A, Gunapalan T, Hesselbacher SE. Use of sodium bicarbonate and blood gas monitoring in diabetic ketoacidosis: A review. World J Diabetes 2018; 9(11): 199-205
- URL: https://www.wjgnet.com/1948-9358/full/v9/i11/199.htm
- DOI: https://dx.doi.org/10.4239/wjd.v9.i11.199
